Compare Stocks: SAUHY, BSX, BDX, and EW

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BDX Becton, Dickinson and Company	$187.23 -0.5%	$167.95	$127.59 ▼ $193.07	$51.83B	0.21	1.85 million shs	1.28 million shs
BSX Boston Scientific	$48.05 -0.5%	$46.69	$42.20 ▼ $109.50	$70.00B	0.57	19.37 million shs	12.00 million shs
EW Edwards Lifesciences	$90.78 +0.0%	$89.71	$72.30 ▼ $96.29	$52.25B	0.85	2.98 million shs	2.54 million shs
SAUHY Straumann	$11.88 +2.9%	$12.44	$9.44 ▼ $13.61	$18.42B	1.56	40,821 shs	44,831 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BDX Becton, Dickinson and Company	-0.48%	-1.39%	+12.66%	+28.66%	-2.91%
BSX Boston Scientific	-0.62%	-3.63%	+2.79%	+0.55%	-54.48%
EW Edwards Lifesciences	-0.09%	-0.16%	+5.35%	+5.52%	+11.42%
SAUHY Straumann	+2.86%	+4.12%	-3.77%	+0.34%	+2.24%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BDX Becton, Dickinson and Company	$187.23 -0.5%	$167.95	$127.59 ▼ $193.07	$51.83B	0.21	1.85 million shs	1.28 million shs
BSX Boston Scientific	$48.05 -0.5%	$46.69	$42.20 ▼ $109.50	$70.00B	0.57	19.37 million shs	12.00 million shs
EW Edwards Lifesciences	$90.78 +0.0%	$89.71	$72.30 ▼ $96.29	$52.25B	0.85	2.98 million shs	2.54 million shs
SAUHY Straumann	$11.88 +2.9%	$12.44	$9.44 ▼ $13.61	$18.42B	1.56	40,821 shs	44,831 shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BDX Becton, Dickinson and Company	-0.48%	-1.39%	+12.66%	+28.66%	-2.91%
BSX Boston Scientific	-0.62%	-3.63%	+2.79%	+0.55%	-54.48%
EW Edwards Lifesciences	-0.09%	-0.16%	+5.35%	+5.52%	+11.42%
SAUHY Straumann	+2.86%	+4.12%	-3.77%	+0.34%	+2.24%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BDX Becton, Dickinson and Company	2.41	Hold	$187.67	0.23% Upside
BSX Boston Scientific	2.71	Moderate Buy	$71.62	49.04% Upside
EW Edwards Lifesciences	2.74	Moderate Buy	$100.27	10.46% Upside
SAUHY Straumann	2.14	Hold	N/A	N/A

Current Analyst Ratings Breakdown

Latest SAUHY, BSX, BDX, and EW Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/1/2026	SAUHY Straumann	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Neutral ➝ Buy
8/31/2026	BDX Becton, Dickinson and Company	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$185.00 ➝ $200.00
8/25/2026	BSX Boston Scientific	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$56.00
8/21/2026	SAUHY Straumann	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Hold
8/13/2026	BDX Becton, Dickinson and Company	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/13/2026	BDX Becton, Dickinson and Company	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Sector Perform	$180.00 ➝ $190.00
8/7/2026	BDX Becton, Dickinson and Company	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D+)
8/7/2026	BDX Becton, Dickinson and Company	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$195.00
8/7/2026	BDX Becton, Dickinson and Company	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Sector Perform	$175.00 ➝ $180.00
8/7/2026	BDX Becton, Dickinson and Company	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sector Perform ➝ Hold
8/7/2026	BDX Becton, Dickinson and Company	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$198.00 ➝ $204.00

(Data available from 9/2/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BDX Becton, Dickinson and Company	$21.84B	2.36	$22.97 per share	8.15	$88.61 per share	2.11
BSX Boston Scientific	$20.07B	3.47	$4.01 per share	11.97	$17.37 per share	2.77
EW Edwards Lifesciences	$6.51B	8.03	$2.85 per share	31.82	$18.63 per share	4.87
SAUHY Straumann	$3.14B	6.03	$0.49 per share	24.08	$1.64 per share	7.24

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BDX Becton, Dickinson and Company	$1.68B	$3.32	56.39	14.14	13.26	4.52%	14.79%	6.93%	11/5/2026 (Estimated)
BSX Boston Scientific	$2.90B	$2.47	19.45	14.05	1.12	17.50%	19.28%	10.89%	10/28/2026 (Estimated)
EW Edwards Lifesciences	$1.07B	$1.74	52.17	26.78	2.38	15.43%	15.68%	12.05%	10/29/2026 (Estimated)
SAUHY Straumann	$429.59M	N/A	N/A	24.24	2.10	N/A	N/A	N/A	N/A

Latest SAUHY, BSX, BDX, and EW Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q3 2026	BDX Becton, Dickinson and Company	$3.14	$3.23	+$0.09	$1.37	$4.89 billion	$4.98 billion
7/29/2026	Q2 2026	BSX Boston Scientific	$0.83	$0.86	+$0.03	$0.61	$5.38 billion	$5.44 billion
7/23/2026	Q2 2026	EW Edwards Lifesciences	$0.7430	$0.78	+$0.0370	$0.42	$1.70 billion	$1.74 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BDX Becton, Dickinson and Company	$4.20	2.24%	+5.65%	126.51%	53 Years
BSX Boston Scientific	N/A	N/A	N/A	N/A	N/A
EW Edwards Lifesciences	N/A	N/A	N/A	N/A	N/A
SAUHY Straumann	$0.06	0.51%	N/A	N/A	N/A

Latest SAUHY, BSX, BDX, and EW Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/28/2026	BDX Becton, Dickinson and Company	quarterly	$1.05	2.53%	9/9/2026	9/9/2026	9/30/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BDX Becton, Dickinson and Company	0.55	0.87	0.51
BSX Boston Scientific	0.43	1.24	0.74
EW Edwards Lifesciences	0.06	4.52	3.77
SAUHY Straumann	N/A	2.21	1.57

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BDX Becton, Dickinson and Company	86.97%
BSX Boston Scientific	89.07%
EW Edwards Lifesciences	79.46%
SAUHY Straumann	N/A

Insider Ownership

Company	Insider Ownership
BDX Becton, Dickinson and Company	0.40%
BSX Boston Scientific	0.34%
EW Edwards Lifesciences	0.31%
SAUHY Straumann	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BDX Becton, Dickinson and Company	72,000	275.54 million	274.44 million	Optionable
BSX Boston Scientific	59,000	1.45 billion	1.44 billion	Optionable
EW Edwards Lifesciences	16,000	575.80 million	574.02 million	Optionable
SAUHY Straumann	11,319	1.59 billion	N/A	Not Optionable

SAUHY, BSX, BDX, and EW Headlines

Recent News About These Companies

HSIC vs. SAUHY: Which Stock Is the Better Value Option?

August 25, 2026 | zacks.com

HSIC vs. SAUHY: Which Stock Is the Better Value Option?

August 25, 2026 | uk.finance.yahoo.com

Straumann Holding AG (SAUHY) Q2 2026 Earnings Call Transcript

August 19, 2026 | seekingalpha.com

Straumann Holding AG ADR SAUHY

August 18, 2026 | morningstar.comM

HSIC or SAUHY: Which Is the Better Value Stock Right Now?

August 6, 2026 | zacks.com

ALGN vs. SAUHY: Which Stock Is the Better Value Option?

July 13, 2026 | zacks.com

ALGN or SAUHY: Which Is the Better Value Stock Right Now?

June 25, 2026 | zacks.com

COO or SAUHY: Which Is the Better Value Stock Right Now?

May 22, 2026 | zacks.com

COO vs. SAUHY: Which Stock Is the Better Value Option?

May 6, 2026 | zacks.com

Straumann Holding AG (SAUHY) Q1 2026 Earnings Call Transcript

April 29, 2026 | seekingalpha.com

COO or SAUHY: Which Is the Better Value Stock Right Now?

April 20, 2026 | zacks.com

Straumann Holding Stock Price, Quotes and Forecasts | OTC:SAUHY | Benzinga

April 8, 2026 | benzinga.com

COO vs. SAUHY: Which Stock Is the Better Value Option?

April 3, 2026 | zacks.com

COO or SAUHY: Which Is the Better Value Stock Right Now?

March 18, 2026 | zacks.com

MMSI vs. SAUHY: Which Stock Is the Better Value Option?

March 2, 2026 | zacks.com

Straumann Holding AG (SAUHY) Q4 2025 Earnings Call Transcript

February 18, 2026 | seekingalpha.com

Straumann Holding AG (OTCMKTS:SAUHY) Given Average Rating of â€œHoldâ€ by Analysts

February 16, 2026 | defenseworld.netD

MMSI vs. SAUHY: Which Stock Should Value Investors Buy Now?

February 12, 2026 | zacks.com

Straumann (OTCMKTS:SAUHY) Shares Gap Up â€“ Should You Buy?

February 8, 2026 | defenseworld.netD

Straumann Holding AG - depositary receipt (SAUHY) price target increased by 30.56% to 35.61

February 4, 2026 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

SAUHY, BSX, BDX, and EW Company Descriptions

Becton, Dickinson and Company NYSE:BDX

$187.23 -0.88 (-0.47%)

Closing price 09/1/2026 03:58 PM Eastern

Extended Trading

$187.01 -0.22 (-0.12%)

As of 04:03 AM Eastern

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Boston Scientific NYSE:BSX

$48.05 -0.25 (-0.52%)

Closing price 09/1/2026 03:58 PM Eastern

Extended Trading

$48.20 +0.15 (+0.31%)

As of 06:01 AM Eastern

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Edwards Lifesciences NYSE:EW

$90.78 +0.03 (+0.03%)

Closing price 09/1/2026 03:58 PM Eastern

Extended Trading

$90.75 -0.03 (-0.03%)

As of 04:00 AM Eastern

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Straumann OTCMKTS:SAUHY

$11.88 +0.33 (+2.86%)

As of 09/1/2026 03:58 PM Eastern

Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implants and components made from titanium, titanium alloy, and ceramics; prosthetic elements made od ceramics, metal or polymer; and clear aligners. In addition, it offers resins for 3D printing and thermoplastics for clear aligner production; and biomaterials for tissue generation. Further, it provides digital equipment comprising scanners, milling machines and 3D printers. Further, it offers training and education services. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SAUHY, BSX, BDX, and EW Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SAUHY, BSX, BDX, and EW Earnings

Compare Dividends

Latest SAUHY, BSX, BDX, and EW Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SAUHY, BSX, BDX, and EW Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

SAUHY, BSX, BDX, and EW Company Descriptions

Becton, Dickinson and Company NYSE:BDX

Boston Scientific NYSE:BSX

Edwards Lifesciences NYSE:EW

Straumann OTCMKTS:SAUHY

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools